mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.4 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.4 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |